{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:03:21Z","timestamp":1775509401262,"version":"3.50.1"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL), accounting for approximately 50% of all CTCLs. Although various molecular changes in MF have been described in existing studies, no obvious disease-specific changes have been found thus far. microRNAs (miRs) are short, noncoding RNA molecules that play roles in the post-transcriptional regulation of oncogenes and tumor suppressor genes in various diseases. Recently, there has been rapidly expanding experimental evidence for the role of miRs in the progression, early diagnosis, prognosis prediction for MF. Efforts to improve early diagnosis and develop personalized therapy options have become more important in recent years. Here, we provide an overview and update of recent advances regarding miRs associated with MF. Furthermore, we provide insights into future opportunities for miR-based therapies.<\/jats:p>","DOI":"10.3389\/fonc.2021.752817","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T06:22:12Z","timestamp":1639376532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides"],"prefix":"10.3389","volume":"11","author":[{"given":"Pengfei","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08852.x","article-title":"Incidence of Primary Cutaneous T-Cell Lymphoma in Norway","volume":"160","author":"Saunes","year":"2009","journal-title":"Br J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25577","article-title":"Mycosis Fungoides and Sezary Syndrome: 2019 Update on Diagnosis, Risk-Stratification, and Management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival Outcomes and Prognostic Factors in Mycosis Fungoides\/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer Staging Proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-Cell Lymphoma (Mycosis Fungoides and Sezary Syndrome)","volume":"155","author":"Wong","year":"2011","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-Cell Clonality Analysis in Biopsy Specimens From Two Different Skin Sites Shows High Specificity in the Diagnosis of Patients With Suggested Mycosis Fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.56.1.1","article-title":"Diagnostic Role of Tests for T Cell Receptor (TCR) Genes","volume":"56","author":"Hodges","year":"2003","journal-title":"J Clin Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701109","article-title":"TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples","volume":"128","author":"Ponti","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00765","article-title":"Update on Biology of Cutaneous T-Cell Lymphoma","volume":"10","author":"Phyo","year":"2020","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1997","article-title":"MicroRNA Signatures in Human Cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4161\/cc.24987","article-title":"STAT5-Mediated Expression of Oncogenic miR-155 in Cutaneous T-Cell Lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2796","DOI":"10.1038\/cddis.2017.119","article-title":"MiR-106b and miR-93 Regulate Cell Progression by Suppression of PTEN via PI3K\/Akt Pathway in Breast Cancer","volume":"8","author":"Li","year":"2017","journal-title":"Cell Death Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-015-9897-8","article-title":"Altered microRNA Expression in Folliculotropic and Transformed Mycosis Fungoides","volume":"21","author":"Marosvari","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3306","article-title":"The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sezary Syndrome","volume":"99","author":"Rittig","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA Expression Profiling of Mycosis Fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Mol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1500","article-title":"MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma","volume":"138","author":"Shen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10669.x","article-title":"Altered microRNA Expression in Mycosis Fungoides","volume":"166","author":"Maj","year":"2012","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12161","article-title":"miR-155 Is Involved in Tumor Progression of Mycosis Fungoides","volume":"22","author":"Moyal","year":"2013","journal-title":"Exp Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 Are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas","volume":"18","author":"Dusilkova","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/bjd.15422","article-title":"Oncogenic Role of microRNA-155 in Mycosis Fungoides: An In Vitro and Xenograft Mouse Model Study","volume":"177","author":"Moyal","year":"2017","journal-title":"Br J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.01.038","article-title":"Staphylococcus Aureus Induces Signal Transducer and Activator of Transcription 5dependent miR-155 Expression in Cutaneous T-Cell Lymphoma","author":"Willerslev-Olsen","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13832","article-title":"The \"Duvic Regimen\" for Erythrodermic Flares Secondary to Staphylococcus Aureus in Mycosis Fungoides and Sezary Syndrome","volume":"57","author":"Lewis","year":"2018","journal-title":"Int J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5259-8","article-title":"Genomic Imbalances and microRNA Transcriptional Profiles in Patients With Mycosis Fungoides","volume":"37","author":"Garaicoa","year":"2016","journal-title":"Tumour Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA Profiling in Cutaneous T-Cell Lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and Treatment of Staphylococcus Aureus Colonization in Patients With Mycosis Fungoides and Sezary Syndrome","volume":"159","author":"Talpur","year":"2008","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Co-Ordinately Regulates Multiple Survival Pathways to Reduce Cellular Proliferation and Survival in Cutaneous T-Cell Lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"adv00230","DOI":"10.2340\/00015555-3578","article-title":"Stage-Dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-Associated Inflammatory Cells in Folliculotropic Mycosis Fungoides","volume":"100","author":"Atzmony","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20519","article-title":"Mycosis Fungoides-Derived Exosomes Promote Cell Motility and Are Enriched With microRNA-155 and microRNA-1246, and Their Plasma-Cell-Free Expression May Serve as a Potential Biomarker for Disease Burden","author":"Moyal","year":"2021","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000505743","article-title":"MicroRNA-93 Targets P21 and Promotes Proliferation in Mycosis Fungoides T Cells","volume":"237","author":"Gluud","year":"2021","journal-title":"Dermatology"},{"key":"B30","article-title":"MicroRNA Expression in Early Mycosis Fungoides Is Distinctly Different From Atopic Dermatitis and Advanced Cutaneous T-Cell Lymphoma","volume":"34","author":"Ralfkiaer","year":"2014","journal-title":"Anticancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0224305","DOI":"10.1371\/journal.pone.0224305","article-title":"Potential Role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in Diagnosis and Prediction of Disease Progression in Mycosis Fungoides in Egyptian Patients","volume":"14","author":"Talaat","year":"2019","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.461","article-title":"miR-223 Regulates Cell Growth and Targets Proto-Oncogenes in Mycosis Fungoides\/Cutaneous T-Cell Lymphoma","volume":"134","author":"McGirt","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0198477","DOI":"10.1371\/journal.pone.0198477","article-title":"Mycosis Fungoides Progression Could be Regulated by microRNAs","volume":"13","author":"Manso","year":"2018","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics Inhibit Tumor and Disease Activity in Cutaneous T-Cell Lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-788950","article-title":"Prognostic miRNA Classifier in Early-Stage Mycosis Fungoides: Development and Validation in a Danish Nationwide Study","volume":"131","author":"Lindahl","year":"2018","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"adv00270","DOI":"10.2340\/00015555-3574","article-title":"MicroRNA-106b Regulates Expression of the Tumour Suppressors P21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides","volume":"100","author":"Lindahl","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17425","article-title":"Unilesional Mycosis Fungoides Is Associated With Increased Expression of microRNA-17~92 and T Helper 1 Skewing","volume":"180","author":"Moyal","year":"2019","journal-title":"Br J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 Inhibit Expression of miR-22, a Novel Tumor Suppressor microRNA, in Cutaneous T-Cell Lymphoma","volume":"6","author":"Sibbesen","year":"2015","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14124","article-title":"Suppressed microRNA-195-5p Expression in Mycosis Fungoides Promotes Tumor Cell Proliferation","author":"Rittig","year":"2020","journal-title":"Exp Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e29541","DOI":"10.1371\/journal.pone.0029541","article-title":"miR-122 Regulates P53\/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma","volume":"7","author":"Manfe","year":"2012","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12571","article-title":"Early Changes in miRNA Expression Are Predictive of Response to Extracorporeal Photopheresis in Cutaneous T-Cell Lymphoma","volume":"29","author":"McGirt","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1101372","article-title":"Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells","volume":"305","author":"Morris","year":"2004","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1039\/c8nr03604g","article-title":"Towards Personalised Rapid Label Free miRNA Detection for Cancer and Liver Injury Diagnostics in Cell Lysates and Blood Based Samples","volume":"10","author":"Duffy","year":"2018","journal-title":"Nanoscale"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1038\/s41598-020-66062-1","article-title":"The Value of Circulating microRNAs for Early Diagnosis of B-Cell Lymphoma: A Case-Control Study on Historical Samples","volume":"10","author":"J\u00f8rgensen","year":"2020","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41420-018-0089-7","article-title":"Downregulated Circulating microRNAs After Surgery: Potential Noninvasive Biomarkers for Diagnosis and Prognosis of Early Breast Cancer","volume":"4","author":"Wang","year":"2018","journal-title":"Cell Death Discovery"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4359","article-title":"Therapeutic Targeting of microRNAs: Current Status and Future Challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat Rev Drug Discovery"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5325-2","article-title":"Aberrant microRNA Expression in Tumor Mycosis Fungoides","volume":"37","author":"Papadavid","year":"2016","journal-title":"Tumour Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051229","article-title":"MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas","volume":"12","author":"Gluud","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated microRNA in Cutaneous T-Cell Lymphoma","volume":"135","author":"Sandoval","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/path.4539","article-title":"Oncogenic Role of miR-155 in Anaplastic Large Cell Lymphoma Lacking the T(2;5) Translocation","volume":"236","author":"Merkel","year":"2015","journal-title":"J Pathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA Profiling Reveals That miR-21, Mir486 and miR-214 Are Upregulated and Involved in Cell Survival in Sezary Syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-256719","article-title":"MicroRNA Expression in Sezary Syndrome: Identification, Function, and Diagnostic Potential","volume":"116","author":"Ballabio","year":"2010","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.08.011","article-title":"High Expression of Dicer Reveals a Negative Prognostic Influence in Certain Subtypes of Primary Cutaneous T Cell Lymphomas","volume":"64","author":"Valencak","year":"2011","journal-title":"J Dermatol science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.05.006","article-title":"Over Expression of Circulating miR-155 Predicts Prognosis in Diffuse Large B-Cell Lymphoma","volume":"70","author":"Ahmadvand","year":"2018","journal-title":"Leuk Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.18","article-title":"Exosomes Confer Chemoresistance to Pancreatic Cancer Cells by Promoting ROS Detoxification and miR-155-Mediated Suppression of Key Gemcitabine-Metabolising Enzyme, DCK","volume":"116","author":"Patel","year":"2017","journal-title":"Br J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.11.692","article-title":"Infectious Agents in Cutaneous T-Cell Lymphoma","volume":"64","author":"Mirvish","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.01.009","article-title":"Role of Infectious Agents in Cutaneous T-Cell Lymphoma: Facts and Controversies","volume":"31","author":"Mirvish","year":"2013","journal-title":"Clin Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e318276cc68","article-title":"Expression of PTEN in Mycosis Fungoides and Correlation With Loss of Heterozygosity","volume":"35","author":"Katona","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1266","article-title":"Mirtarbase Update 2014: An Information Resource for Experimentally Validated miRNA-Target Interactions","volume":"42","author":"Hsu","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2013.78.020024","article-title":"miR-181 and Metabolic Regulation in the Immune System","volume":"78","author":"Williams","year":"2013","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06868.x","article-title":"MicroRNAs in the Pathogeny of Chronic Lymphocytic Leukaemia","volume":"139","author":"Nicoloso","year":"2007","journal-title":"Br J Haematol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 Down-Regulation in Pituitary Adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J Cell Physiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","article-title":"Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance Through CXCL12\/CXCR4","volume":"141","author":"Aronovich","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18353","article-title":"Deregulated Signalling and Inflammation in Cutaneous T-Cell Lymphoma","volume":"182","author":"Odum","year":"2020","journal-title":"Br J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2300","article-title":"miRNA-22 Suppresses Colon Cancer Cell Migration and Invasion by Inhibiting the Expression of T-Cell Lymphoma Invasion and Metastasis 1 and Matrix Metalloproteinases 2 and 9","volume":"29","author":"Li","year":"2013","journal-title":"Oncol Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining Early Mycosis Fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1177\/107327480701400203","article-title":"The Diagnosis, Staging, and Treatment Options for Mycosis Fungoides","volume":"14","author":"Keehn","year":"2007","journal-title":"Cancer Control"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-Cell Lymphoma: 2016 Update on Diagnosis, Risk-Stratification, and Management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.815352","article-title":"Validation of a Diagnostic microRNA Classifier in Cutaneous T-Cell Lymphomas","volume":"55","author":"Marstrand","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15355","article-title":"Recommendations for Treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group","volume":"177","author":"van Santen","year":"2017","journal-title":"Br J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamadermatol.2016.1597","article-title":"Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides","volume":"152","author":"van Santen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B75","article-title":"Transformation of Mycosis Fungoides: Clinicopathological and Prognostic Features of 45 Cases. French Study Group of Cutaneious Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic Factors in Transformed Mycosis Fungoides: A Retrospective Analysis of 100 Cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.05.001","article-title":"Outcomes of Patients With Transformed Mycosis Fungoides: Analysis From a Prospective Multicenter US Cohort Study","volume":"20","author":"Lansigan","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.009","article-title":"New Insights Into Folliculotropic Mycosis Fungoides (FMF): A Single-Center Experience","volume":"75","author":"Hodak","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.02.003","article-title":"Transgene-Derived Overexpression of miR-17-92 in CD8+ T-Cells Confers Enhanced Cytotoxic Activity","volume":"458","author":"Kosaka","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-1-21","article-title":"Expression of miR-17-92 Enhances Anti-Tumor Activity of T-Cells Transduced With the Anti-EGFRvIII Chimeric Antigen Receptor in Mice Bearing Human GBM Xenografts","volume":"1","author":"Ohno","year":"2013","journal-title":"J Immunother Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-792150","article-title":"Synergy of BCL2 and Histone Deacetylase Inhibition Against Leukemic Cells From Cutaneous T-Cell Lymphoma Patients","volume":"130","author":"Cyrenne","year":"2017","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/cncr.11593","article-title":"Multicenter Study of Pegylated Liposomal Doxorubicin in Patients With Cutaneous T-Cell Lymphoma","volume":"98","author":"Wollina","year":"2003","journal-title":"Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13965","article-title":"Development of miRNA-Based Therapeutic Approaches for Cancer Patients","volume":"110","author":"Takahashi","year":"2019","journal-title":"Cancer Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14289","article-title":"Borrelia Burgdorferi in Primary Cutaneous Lymphomas: A Systematic Review and Meta-Analysis","volume":"18","author":"Travaglino","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602997","article-title":"Mycosis Fungoides: Is It a Borrelia Burgdorferi-Associated Disease","volume":"94","author":"Tothova","year":"2006","journal-title":"Br J Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.2001.tb03712.x","article-title":"Association Between S\u00e9zary T Cell-Activating Factor, Chlamydia Pneumoniae, and Cutaneous T Cell Lymphoma","volume":"941","author":"Abrams","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"152391","DOI":"10.1016\/j.prp.2019.03.019","article-title":"Associations of High Expression of miR-106b-5p Detected From FFPE Sample With Poor Prognosis of RCC Patients","volume":"215","author":"Liu","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.820.820","article-title":"Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients","volume":"1","author":"Querfeld","year":"2017","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.752817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T06:22:15Z","timestamp":1639376535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.752817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":88,"alternative-id":["10.3389\/fonc.2021.752817"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.752817","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]},"article-number":"752817"}}